Disseminated toxoplasmosis and haemophagocytic lymphohistiocytosis following chimeric antigen receptor T-cell therapy.

Autor: Kator S; Department of Pharmacy, Intermountain LDS Hospital, Salt Lake City, UT, USA., Zurko J; Department of Infectious Disease, University of Utah, Salt Lake City, UT, USA., Webb BJ; Division of Infectious Diseases and Clinical Epidemiology, Intermountain Healthcare, Salt Lake City, UT, USA.; Division of Infectious Diseases and Geographic Medicine, Stanford University, Palo Alto, CA, USA., Balatico MA; Department of Pathology, University of Utah, Salt Lake City, UT, USA., Clayton F; Department of Pathology, University of Utah, Salt Lake City, UT, USA., Palmer CA; Department of Pathology, University of Utah, Salt Lake City, UT, USA., Konopa K; Intermountain Blood and Marrow Transplant and Acute Leukemia Program, Intermountain Healthcare, Salt Lake City, UT, USA., Motyckova G; Intermountain Blood and Marrow Transplant and Acute Leukemia Program, Intermountain Healthcare, Salt Lake City, UT, USA., Ford CD; Intermountain Blood and Marrow Transplant and Acute Leukemia Program, Intermountain Healthcare, Salt Lake City, UT, USA., Ostronoff F; Intermountain Blood and Marrow Transplant and Acute Leukemia Program, Intermountain Healthcare, Salt Lake City, UT, USA.

Publikováno v: British journal of haematology [Br J Haematol] 2020 Apr; Vol. 189 (1), pp. e4-e6. Date of Electronic Publication: 2020 Jan 20.